N-Methanocarbathymidine is more effective than acyclovir for treating neonatal herpes simplex virus infection in guinea pigs. 2011

David I Bernstein, and Fernando J Bravo, and Jennifer R Clark, and Julie D Earwood, and Aquilur Rahman, and Robert Glazer, and Rhonda D Cardin
Cincinnati Children's Hospital Medical Center, University of Cincinnati, Cincinnati, OH, United States. David.Bernstein@cchmc.org

The outcome of neonatal herpes simplex (HSV) infection, even after therapy with high dose acyclovir (ACV), is not optimum. We therefore evaluated N-Methanocarbathymidine ((N)-MCT) using the guinea pig model of neonatal herpes. Treatment with ACV (60 mg/kg/day) was compared to doses of 1, 5, and 25 mg/kg/day of (N)-MCT initiated 1, 2, or 3 days postinoculation (dpi). Both ACV and (N)-MCT significantly improved survival, but only (N)-MCT significantly reduced the number of animals with symptoms when begun at 1 dpi. When therapy was begun at 2 dpi, only (N)-MCT (1, 5, or 25 mg/kg/day) significantly increased survival. In fact, (N)-MCT improved survival up to 3 dpi, the last time point evaluated. (N)-MCT was highly effective and superior to high dose ACV therapy for the treatment of neonatal herpes in the guinea pig model.

UI MeSH Term Description Entries
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D011251 Pregnancy Complications, Infectious The co-occurrence of pregnancy and an INFECTION. The infection may precede or follow FERTILIZATION. Complications, Infectious Pregnancy,Infectious Pregnancy Complications,Maternal Sepsis,Pregnancy, Infectious Complications,Sepsis during Pregnancy,Sepsis in Pregnancy,Infectious Pregnancy Complication,Pregnancy Complication, Infectious,Sepsis in Pregnancies,Sepsis, Maternal
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D006168 Guinea Pigs A common name used for the genus Cavia. The most common species is Cavia porcellus which is the domesticated guinea pig used for pets and biomedical research. Cavia,Cavia porcellus,Guinea Pig,Pig, Guinea,Pigs, Guinea
D006561 Herpes Simplex A group of acute infections caused by herpes simplex virus type 1 or type 2 that is characterized by the development of one or more small fluid-filled vesicles with a raised erythematous base on the skin or mucous membrane. It occurs as a primary infection or recurs due to a reactivation of a latent infection. (Dorland, 27th ed.) Herpes Simplex Virus Infection
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000212 Acyclovir A GUANOSINE analog that acts as an antimetabolite. Viruses are especially susceptible. Used especially against herpes. Acycloguanosine,9-((2-Hydroxyethoxy)methyl)guanine,Aci-Sanorania,Acic,Aciclobeta,Aciclostad,Aciclovir,Aciclovir Alonga,Aciclovir-Sanorania,Acifur,Acipen Solutab,Acivir,Activir,Acyclo-V,Acyclovir Sodium,Antiherpes Creme,Avirax,Cicloferon,Clonorax,Cusiviral,Genvir,Herpetad,Herpofug,Herpotern,Herpoviric,Isavir,Laciken,Mapox,Maynar,Milavir,Opthavir,Supraviran,Viclovir,Vipral,Virax-Puren,Virherpes,Virmen,Virolex,Virupos,Virzin,Wellcome-248U,Zoliparin,Zovirax,Zyclir,aciclovir von ct,Aci Sanorania,Aciclovir Sanorania,Acyclo V,Alonga, Aciclovir,Sodium, Acyclovir,Solutab, Acipen,Virax Puren,ViraxPuren,Wellcome 248U,Wellcome248U
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000831 Animals, Newborn Refers to animals in the period of time just after birth. Animals, Neonatal,Animal, Neonatal,Animal, Newborn,Neonatal Animal,Neonatal Animals,Newborn Animal,Newborn Animals
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral

Related Publications

David I Bernstein, and Fernando J Bravo, and Jennifer R Clark, and Julie D Earwood, and Aquilur Rahman, and Robert Glazer, and Rhonda D Cardin
September 1982, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
David I Bernstein, and Fernando J Bravo, and Jennifer R Clark, and Julie D Earwood, and Aquilur Rahman, and Robert Glazer, and Rhonda D Cardin
August 2012, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians,
David I Bernstein, and Fernando J Bravo, and Jennifer R Clark, and Julie D Earwood, and Aquilur Rahman, and Robert Glazer, and Rhonda D Cardin
June 1980, Archives of dermatology,
David I Bernstein, and Fernando J Bravo, and Jennifer R Clark, and Julie D Earwood, and Aquilur Rahman, and Robert Glazer, and Rhonda D Cardin
January 1982, Pediatric infectious disease,
David I Bernstein, and Fernando J Bravo, and Jennifer R Clark, and Julie D Earwood, and Aquilur Rahman, and Robert Glazer, and Rhonda D Cardin
September 1984, Ugeskrift for laeger,
David I Bernstein, and Fernando J Bravo, and Jennifer R Clark, and Julie D Earwood, and Aquilur Rahman, and Robert Glazer, and Rhonda D Cardin
November 1987, Antimicrobial agents and chemotherapy,
David I Bernstein, and Fernando J Bravo, and Jennifer R Clark, and Julie D Earwood, and Aquilur Rahman, and Robert Glazer, and Rhonda D Cardin
March 1987, Antimicrobial agents and chemotherapy,
David I Bernstein, and Fernando J Bravo, and Jennifer R Clark, and Julie D Earwood, and Aquilur Rahman, and Robert Glazer, and Rhonda D Cardin
June 1994, The Journal of pediatrics,
David I Bernstein, and Fernando J Bravo, and Jennifer R Clark, and Julie D Earwood, and Aquilur Rahman, and Robert Glazer, and Rhonda D Cardin
January 1985, Intervirology,
David I Bernstein, and Fernando J Bravo, and Jennifer R Clark, and Julie D Earwood, and Aquilur Rahman, and Robert Glazer, and Rhonda D Cardin
August 1995, The Journal of infectious diseases,
Copied contents to your clipboard!